| Understanding the role of ETS-mediated gene regulation in complex biological processes VJ Findlay, AC LaRue, DP Turner, PM Watson, DK Watson Advances in cancer research 119, 1-61, 2013 | 121 | 2013 |
| Advanced glycation end-products: a biological consequence of lifestyle contributing to cancer disparity DP Turner Cancer research 75 (10), 1925-1929, 2015 | 113 | 2015 |
| The DNA N-Glycosylase MED1 Exhibits Preference for Halogenated Pyrimidines and Is Involved in the Cytotoxicity of 5-Iododeoxyuridine DP Turner, S Cortellino, JE Schupp, E Caretti, T Loh, TJ Kinsella, ... Cancer research 66 (15), 7686-7693, 2006 | 79 | 2006 |
| AGE metabolites: a biomarker linked to cancer disparity? D Foster, L Spruill, KR Walter, LM Nogueira, H Fedarovich, RY Turner, ... Cancer Epidemiology, Biomarkers & Prevention 23 (10), 2186-2191, 2014 | 78 | 2014 |
| Prostate-derived ETS factor is a mediator of metastatic potential through the inhibition of migration and invasion in breast cancer DP Turner, O Moussa, M Sauane, PB Fisher, DK Watson Cancer research 67 (4), 1618-1625, 2007 | 77 | 2007 |
| ETS transcription factors: oncogenes and tumor suppressor genes as therapeutic targets for prostate cancer DP Turner, DK Watson Expert review of anticancer therapy 8 (1), 33-42, 2008 | 75 | 2008 |
| MicroRNA-mediated inhibition of prostate-derived Ets factor messenger RNA translation affects prostate-derived Ets factor regulatory networks in human breast cancer VJ Findlay, DP Turner, O Moussa, DK Watson Cancer research 68 (20), 8499-8506, 2008 | 73 | 2008 |
| Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression DP Turner, VJ Findlay, O Moussa, VI Semenchenko, PM Watson, ... The Prostate 71 (16), 1723-1735, 2011 | 72 | 2011 |
| MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer QJ Guo, JN Mills, SG Bandurraga, LM Nogueira, NJ Mason, ER Camp, ... Breast Cancer Research 15, 1-13, 2013 | 67 | 2013 |
| Transcriptional regulation of p21/CIP1 cell cycle inhibitor by PDEF controls cell proliferation and mammary tumor progression JS Schaefer, Y Sabherwal, HY Shi, V Sriraman, JA Richards, A Minella, ... Journal of Biological Chemistry 285 (15), 11258-11269, 2010 | 67 | 2010 |
| Defining ETS transcription regulatory networks and their contribution to breast cancer progression DP Turner, VJ Findlay, O Moussa, DK Watson Journal of cellular biochemistry 102 (3), 549-559, 2007 | 67 | 2007 |
| In-Situ Polymerization Controls CO2/Water Channeling at Lick Creek P Woods, K Schramko, D Turner, D Dalrymple, E Vinson SPE Improved Oil Recovery Conference?, SPE-14958-MS, 1986 | 61 | 1986 |
| Global gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progression DP Turner, VJ Findlay, AD Kirven, O Moussa, DK Watson Molecular biology of the cell 19 (9), 3745-3757, 2008 | 60 | 2008 |
| Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention KR Walter, ME Ford, MJ Gregoski, RM Kramer, KD Knight, L Spruill, ... Breast cancer research and treatment 173, 559-571, 2019 | 56 | 2019 |
| PDEF is a negative regulator of colon cancer cell growth and migration O Moussa, DP Turner, RJ Feldman, VI Sementchenko, BD McCarragher, ... Journal of cellular biochemistry 108 (6), 1389-1398, 2009 | 56 | 2009 |
| Hematopoietic stem cell–derived cancer–associated fibroblasts are novel contributors to the pro-tumorigenic microenvironment LT McDonald, DL Russell, RR Kelly, Y Xiong, A Motamarry, RK Patel, ... Neoplasia 17 (5), 434-448, 2015 | 44 | 2015 |
| Dietary advanced glycation end-products (AGE) and risk of breast cancer in the prostate, lung, colorectal and ovarian cancer screening trial (PLCO) OO Omofuma, DP Turner, LL Peterson, AT Merchant, J Zhang, SE Steck Cancer Prevention Research 13 (7), 601-610, 2020 | 40 | 2020 |
| ETS1 transcriptional activity is increased in advanced prostate cancer and promotes the castrate-resistant phenotype AM Smith, VJ Findlay, SG Bandurraga, E Kistner-Griffin, LS Spruill, A Liu, ... Carcinogenesis 33 (3), 572-580, 2012 | 37 | 2012 |
| The role of advanced glycation end-products in cancer disparity DP Turner Advances in cancer research 133, 1-22, 2017 | 34 | 2017 |
| Dietary advanced glycation end products and the risk of postmenopausal breast cancer in the National Institutes of Health‐AARP diet and health study LL Peterson, S Park, Y Park, GA Colditz, N Anbardar, DP Turner Cancer 126 (11), 2648-2657, 2020 | 33 | 2020 |
Victoria J FindlayAssociate Professor of Surgery, Virginia Commonwealth University在 vcuhealth.org 的电子邮件经过验证
